High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients

The immune response of liver transplant (LT) recipients to a third dose of the BNT162b2 mRNA vaccine significantly waned after four months. We aimed to evaluate the immune response and breakthrough infection rates of a fourth dose against the Omicron variants among LT recipients. LT recipients who h...

Full description

Bibliographic Details

Published in:	Viruses
Main Authors:	Yana Davidov, Victoria Indenbaum, Nofar Atari, Limor Kliker, Keren Tsaraf, Keren Asraf, Oranit Cohen-Ezra, Mariya Likhter, Orna Mor, Ram Doolman, Yael Weiss-Ottolenghi, Tammy Hod, Arnon Afek, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim, Ziv Ben-Ari
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	BNT162b2 mRNA fourth dose liver transplant recipients breakthrough infection immune response side effects BNT162b2 mRNA vaccine
Online Access:	https://www.mdpi.com/1999-4915/14/12/2769